“Unicorn” start-up Owkin, Inc., “the first end-to-end AI biotech,” is still processing the final text of the European Union’s AI Act, which entered into force on 1 August 2024.
“From a high-level overview of the EU AI Act … we need to make sure that when we build the AI it results in a model that does what it...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?